期刊文献+

风湿性多肌痛患者免疫状态的研究 被引量:2

Studies on status of immunity in patients with polymyalgia rheumatica
下载PDF
导出
摘要 目的: 探讨风湿性多肌痛(PMR) 患者免疫状态的变化。方法: 采用APAAP法和单向免疫扩散法, 对8 例PMR 患者的外周血T细胞亚群及血清免疫球蛋白进行测定, 并以10 例正常人作对照。结果: PMR患者外周血中CD+4细胞数比正常对照组高( P <0-001) , CD+8 细胞数明显低于正常对照组( P<0-001), CD+4 /CD8 细胞比值明显升高( P< 0-001), PMR 患者血清IgG明显高于正常对照组( P < 0-001)。结论: PMR 患者存在着免疫调节紊乱,CD+8 细胞数的降低在PMR发病中可能起着重要作用。 Objective: To investigate the changes of immunity in patients with polymyalgia rheumatica.Methods:The T-cell subsets determination in the peripheral blood and the immunoglobulin levels in serum were measured by alkaline phosphatase-antialkaline phosphatase and simple immunoagar diffusion in 8 patients with PMR and 10 normal Persons. Results:The percentage of CD 4 positive cells and the ratio of CD + 4/CD + 8were increased in these patients with PMR(P<0 001). The percentage of CD 8 positive cells in the patients with PMR were significantly lower than those of the controls(P<0 001).Whereas the lgG level in serum were increased compared with normal controls(P<0 001). Conclusion:These findings indicate that there was immunoregulative disorder in the patients with PMR.The reduction of CD 8maybe play an important part in pathogenesis of PMR.
作者 范成明
出处 《大连医科大学学报》 CAS 1999年第4期266-268,共3页 Journal of Dalian Medical University
关键词 风湿性多肌痛 T细胞亚群 免疫球蛋白 polymyalgia rheumatica T-cell subsets immunoglobulin
  • 相关文献

同被引文献13

  • 1孟济明.风湿性多肌痛诊治指南(草案)[J].中华风湿病学杂志,2004,8(8):506-507. 被引量:24
  • 2傅红卫,池黠,杨虎天,洪景.复方丹参注射液配合泼尼松治疗风湿性多肌痛29例[J].上海中医药杂志,2006,40(2):15-16. 被引量:4
  • 3Healey LA. On the epidemiology of polymyalgia eheumatica and temporal arteritis. J Rheumatol, 1993, 20: 169.
  • 4Arnold MH, Corrigall VM, Pitzais C, et al. The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis. J Clin Exp Rheumatol, 1993, 11(6): 629.
  • 5Elliot JM, Virankabutra T, Jones S, et al. Erythropoietin mimics the acute phase response in critical illness. Crit Care, 2003, 7: R35 -40.
  • 6Ceccato F, Roverano SG, Papasidero S, et al. Peripheral musculoskeletal manifestations in polymyalgia rheumatica. J Clin Rheumatol, 2006, 12(4): 167-171.
  • 7Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentalion rate and C reactive protein in the assessment of polymyalgia rheumatica/gaint cell arteritis on presentation and during follow up. Ann Rheum Dis, 1989, 48: 667.
  • 8Evans J. Polymyalgia rheumatic and giant cell arteritis. Geriatric Rheumatol, 2000, 26: 493-515.
  • 9Anonymous. The management of polymyalgia rheumatica and giant cell arteritis. Drug Ther Bull, 1993, 31: 65-68.
  • 10Narvaez J, Nolla-Sole JM, Clavaguera MT, et al. Long-term therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol, 1999, 26: 1945-1952.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部